Covered recipient · General Payments record
JAMES MATTHEW TAYLOR
Allopathic & Osteopathic Physicians Radiology Radiation Oncology
General Payments · PY2019–2024
$1,102.15
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $180.96 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sumitomo Pharma America, Inc. | $65.20 | 3 |
| Daiichi Sankyo Inc. | $29.60 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $25.16 | 1 |
| Janssen Biotech, Inc. | $24.38 | 1 |
| Pharmacosmos Therapeutics Inc. | $20.47 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Daiichi Sankyo Inc. | $29.60 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089489428 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.15 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101700210 | CMS |
| Janssen Biotech, Inc. | $24.38 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078539289 | CMS |
| Novartis Pharmaceuticals Corporation | $25.16 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087439820 | CMS |
| Pharmacosmos Therapeutics Inc. | $20.47 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154826531 | CMS |
| Sumitomo Pharma America, Inc. | $20.79 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148926978 | CMS |
| Sumitomo Pharma America, Inc. | $21.85 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148926980 | CMS |
| Sumitomo Pharma America, Inc. | $22.56 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148926982 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.